Indications and uses
relieves occasional constipation (irregularity) generally causes bowel movement in 6 to 12 hours
relieves occasional constipation (irregularity) generally causes bowel movement in 6 to 12 hours
shake well before use take preferably at bedtime or as directed by a doctor
Avoid accessive heat. Store at room temperature 15°-30°C (59°-86°F)
Active ingredient (in each 5 ml) purpose
Sennosides 8.8 mg …………………………................Laxative
relieves occasional constipation (irregularity)
generally causes bowel movement in 6 to 12 hours
shake well before use
take preferably at bedtime or as directed by a doctor
Age Starting Dose Maximum Dose
adults and children 12 years 2 - 3 teaspoonfuls 3 teaspoonfuls twice a day
and older once a day
6 years to under 12 years of age 1 - 1½ teaspoonfuls once a day 1½ teaspoonfuls twice a day
2 to under 6 years of age ½ - ¾ teaspoon once a day ¾ teaspoon once a day
under 2 years of age consult a doctor consult a doctor
Do Not Use • laxative products for longer than 1 week
unless directed by a doctor
Ask a doctor or pharmacist before use if you have
• stomach pain • nausea • vomiting
• notice a sudden change in bowel movement that continues
over a period of 2 weeks
Stop use and ask a doctor if
you have rectal bleeding or failure to have a bowel movement
after use of laxative. These may indicate a serious condition
If pregnant or breast-feeding, ask a health
professional before use
Mythylparaben, Propylene Glycol, Propylparaben, Purified Water, Sucrose
In case of accidental overdose, get medical help or contact a Poison Control Center immediately
Questions?
To Report Adverse Drug Event Call 1(877) 225-6999
DISTRIBUTED BY:
ATLANTIC BIOLOGICALS CORP.
20101 N.E 16TH PLACE
MIAMI, FL 33179
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | 4 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | 4 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | 4 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | 4 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | 4 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-8237-1 | SENNA | 72 in 1 BOX, UNIT-DOSE | SYRUP | 72 | 4 | |
| 17856-8237-3 | SENNA | 120 in 1 BOX, UNIT-DOSE | SYRUP | 120 | 4 | |
| 17856-8237-4 | SENNA | 48 in 1 BOX, UNIT-DOSE | SYRUP | 48 | 4 | |
| 17856-8237-5 | SENNA | 72 in 1 BOX, UNIT-DOSE | SYRUP | 72 | 4 | |
| 17856-8237-5 | SENNA | 10 mL in 1 CUP, UNIT-DOSE | SYRUP | 10 | 4 | |
| 17856-8237-6 | SENNA | 5 mL in 1 CUP, UNIT-DOSE | SYRUP | 5 | 4 | |
| 17856-8237-7 | SENNA | 2.5 mL in 1 SYRINGE | SYRUP | 2.5 | 4 | |
| 17856-8237-8 | SENNA | 5 mL in 1 SYRINGE | SYRUP | 5 | 4 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-8237-1 | ML - Milliliter | 17856-8237 | d8613168-c348-481c-b159-d09baaedd940 | 1 | 2021-07-15 |
| 17856-8237-2 | ML - Milliliter | 17856-8237 | 259e62ac-56a0-4176-a183-98e107d6d0cf | 1 | 2022-05-04 |
| 17856-8237-3 | ML - Milliliter | 17856-8237 | 22b76930-4626-4cb0-b051-e659b6671544 | 1 | 2022-11-07 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 17856-8237 | 17856-8237-6, 17856-8237-1, 17856-8237-5, 17856-8237-7, 17856-8237-3, 17856-8237-8, 17856-8237-4 |
| 71399-8237 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
| SUCROSE | C151H8M554 | IACT |
| SENNOSIDES A AND B | 1B5FPI42EN | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SENNA | SENNA | ATLANTIC BIOLOGICALS CORP. | 8b7cc0d5-029b-43f7-a050-8771e7db4551 | 2025-07-31 | Warnings | 17856-8237-1 17856-8237-5 17856-8237-8 17856-8237-7 17856-8237-6 17856-8237-3 17856-8237-4 17856-8237 17856823707 17856823704 17856823705 17856823701 17856823706 17856823703 17856823708 3b3f526b-e72b-4c6d-e063-6394a90a62e3 8b7cc0d5-029b-43f7-a050-8771e7db4551 |
Adverse event summaries are temporarily unavailable. Other product information remains available.